Philip Gordts
@philipgordts.bsky.social
Associate Professor @UCSanDiego @GRTCnews Researching #Glycobiology in #Cardiovascular disease, #Obesity, #Diabetes and #Lipoprotein #metabolism.
New study from the Gordts Lab!
Not all fat is equal. We show that the heparan sulfate composition on adipocytes determines how well fat tissue maintains glucose balance—shaping Type 2 diabetes risk.
Glycotime from uofumandi.bsky.social, U2M2, and Utah CMH
www.sciencedirect.com/science/arti...
Not all fat is equal. We show that the heparan sulfate composition on adipocytes determines how well fat tissue maintains glucose balance—shaping Type 2 diabetes risk.
Glycotime from uofumandi.bsky.social, U2M2, and Utah CMH
www.sciencedirect.com/science/arti...
Adipocyte Heparan Sulfate Determines Type 2 Diabetes Susceptibility in Mice via FGF1-Mediated Glucose Regulation.
Obesity is the principal driver of insulin resistance, and lipodystrophy is also linked with insulin resistance, emphasizing the vital role of adipose…
www.sciencedirect.com
October 13, 2025 at 4:30 PM
New study from the Gordts Lab!
Not all fat is equal. We show that the heparan sulfate composition on adipocytes determines how well fat tissue maintains glucose balance—shaping Type 2 diabetes risk.
Glycotime from uofumandi.bsky.social, U2M2, and Utah CMH
www.sciencedirect.com/science/arti...
Not all fat is equal. We show that the heparan sulfate composition on adipocytes determines how well fat tissue maintains glucose balance—shaping Type 2 diabetes risk.
Glycotime from uofumandi.bsky.social, U2M2, and Utah CMH
www.sciencedirect.com/science/arti...
The University of Utah’s Pathology Dept. & Huntsman Cancer Institute seek a tenure-track faculty (any level) with a passion for the microbiome–cancer interface. Apply by Nov 17, 2025.
👇
utah.peopleadmin.com/postings/187...
#ScienceJobs #Microbiome #CancerResearch @uofumandi.bsky.social @utah.edu
👇
utah.peopleadmin.com/postings/187...
#ScienceJobs #Microbiome #CancerResearch @uofumandi.bsky.social @utah.edu
Microbiology & Immunology/HCI Professor, Associate Professor, Assistant Professor
utah.peopleadmin.com
September 5, 2025 at 10:49 PM
The University of Utah’s Pathology Dept. & Huntsman Cancer Institute seek a tenure-track faculty (any level) with a passion for the microbiome–cancer interface. Apply by Nov 17, 2025.
👇
utah.peopleadmin.com/postings/187...
#ScienceJobs #Microbiome #CancerResearch @uofumandi.bsky.social @utah.edu
👇
utah.peopleadmin.com/postings/187...
#ScienceJobs #Microbiome #CancerResearch @uofumandi.bsky.social @utah.edu
My divisions is hiring faculty! Let me know if you are interested in applying or have questions.
Faculty Search Alert!
The Division of Microbiology & Immunology at @UUtah is growing! We're hiring at all ranks in the tenure track—join a cutting-edge, collaborative research community in stunning Salt Lake City.
utah.peopleadmin.com/postings/186...
#AcademicJobs #Immunology #ScienceCareers
The Division of Microbiology & Immunology at @UUtah is growing! We're hiring at all ranks in the tenure track—join a cutting-edge, collaborative research community in stunning Salt Lake City.
utah.peopleadmin.com/postings/186...
#AcademicJobs #Immunology #ScienceCareers
August 11, 2025 at 7:15 PM
My divisions is hiring faculty! Let me know if you are interested in applying or have questions.
We’re growing!
My lab at the University of Utah @utah.edu is hiring a Senior Laboratory Specialist to work on glycobiology, metabolism, and inflammation.
Interested? Full job description and application:
employment.utah.edu/salt-lake-ci...
#Glycotime #Hiring #NewLab #ResearchJobs
My lab at the University of Utah @utah.edu is hiring a Senior Laboratory Specialist to work on glycobiology, metabolism, and inflammation.
Interested? Full job description and application:
employment.utah.edu/salt-lake-ci...
#Glycotime #Hiring #NewLab #ResearchJobs
June 4, 2025 at 5:40 PM
We’re growing!
My lab at the University of Utah @utah.edu is hiring a Senior Laboratory Specialist to work on glycobiology, metabolism, and inflammation.
Interested? Full job description and application:
employment.utah.edu/salt-lake-ci...
#Glycotime #Hiring #NewLab #ResearchJobs
My lab at the University of Utah @utah.edu is hiring a Senior Laboratory Specialist to work on glycobiology, metabolism, and inflammation.
Interested? Full job description and application:
employment.utah.edu/salt-lake-ci...
#Glycotime #Hiring #NewLab #ResearchJobs
Big news: I’ve joined the University of @utah.edu as an Associate Professor in the Department of Pathology, Division of Microbiology and Immunology @uofumandi.bsky.social! Advancing glycobiology-driven research in metabolism and inflammation. Grateful to my UCSD colleagues. #Glycotime #NewBeginnings
June 4, 2025 at 5:00 PM
Big news: I’ve joined the University of @utah.edu as an Associate Professor in the Department of Pathology, Division of Microbiology and Immunology @uofumandi.bsky.social! Advancing glycobiology-driven research in metabolism and inflammation. Grateful to my UCSD colleagues. #Glycotime #NewBeginnings
Reposted by Philip Gordts
This is the most relevant article to NIH and research cuts I’ve seen.
Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !”
globalnews.ca/news/9793403...
Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !”
globalnews.ca/news/9793403...
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
globalnews.ca
February 9, 2025 at 9:58 PM
This is the most relevant article to NIH and research cuts I’ve seen.
Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !”
globalnews.ca/news/9793403...
Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !”
globalnews.ca/news/9793403...
Reposted by Philip Gordts
UC San Diego Human Milk Institute (HMI) Welcomes Strategic Advisory Board!
hmi.ucsd.edu/about-us/str...
A powerhouse of experts committed to advancing our mission to transform the approach to lifelong health for all people through human milk.
hmi.ucsd.edu/about-us/str...
A powerhouse of experts committed to advancing our mission to transform the approach to lifelong health for all people through human milk.
November 19, 2024 at 4:25 PM
UC San Diego Human Milk Institute (HMI) Welcomes Strategic Advisory Board!
hmi.ucsd.edu/about-us/str...
A powerhouse of experts committed to advancing our mission to transform the approach to lifelong health for all people through human milk.
hmi.ucsd.edu/about-us/str...
A powerhouse of experts committed to advancing our mission to transform the approach to lifelong health for all people through human milk.
Reposted by Philip Gordts
Out this week in #Cell_Metabolism: The work with the Metallo lab @salkinstitute.bsky.social showing that trans-fat promotes hepatic serine palmitoyltransferase flux (SPT), VLDL secretion, and #atherosclerosis. SPT inhibition reduces VLDL and atherosclerosis. www.sciencedirect.com/science/arti...
Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis
Dietary fat drives the pathogenesis of atherosclerotic cardiovascular disease (ASCVD), particularly through circulating cholesterol and triglyceride-r…
www.sciencedirect.com
November 16, 2024 at 11:09 PM
Out this week in #Cell_Metabolism: The work with the Metallo lab @salkinstitute.bsky.social showing that trans-fat promotes hepatic serine palmitoyltransferase flux (SPT), VLDL secretion, and #atherosclerosis. SPT inhibition reduces VLDL and atherosclerosis. www.sciencedirect.com/science/arti...
Check out our collaborative work on GPNMB in cardiac repair with Arjun Debb and Jake Lysis. Together we identified GPNMB as the first protein ligand for orphan receptor GPR39 and uncovered its involvement in post myocardial repair of the heart. go.nature.com/40kBJKS
Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair - Nature Cardiovascular Research
Ramadoss et al. show that bone-marrow-derived macrophages contribute to heart repair following myocardial infarction by secreting GPNMB, which binds to the orphan receptor GPR39 to improve myocyte con...
go.nature.com
November 14, 2024 at 10:31 PM
Check out our collaborative work on GPNMB in cardiac repair with Arjun Debb and Jake Lysis. Together we identified GPNMB as the first protein ligand for orphan receptor GPR39 and uncovered its involvement in post myocardial repair of the heart. go.nature.com/40kBJKS
Check out our collaborative work on GPNMB in cardiac repair with Arjun Debb and Jake Lysis. Together we identified GPNMB as the first protein ligand for orphan receptor GPR39 and uncovered its involvement in post myocardial repair of the heart. go.nature.com/40kBJKS
Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair - Nature Cardiovascular Research
Ramadoss et al. show that bone-marrow-derived macrophages contribute to heart repair following myocardial infarction by secreting GPNMB, which binds to the orphan receptor GPR39 to improve myocyte con...
go.nature.com
November 14, 2024 at 10:30 PM
Check out our collaborative work on GPNMB in cardiac repair with Arjun Debb and Jake Lysis. Together we identified GPNMB as the first protein ligand for orphan receptor GPR39 and uncovered its involvement in post myocardial repair of the heart. go.nature.com/40kBJKS
Happy to share that our work with on how specific #glycans in human milk can be leveraged to reduce chronic inflammation and #atherosclerosis development is published in JCI Insight -https://insight.jci.org/articles/view/181329
November 12, 2024 at 3:22 PM
Happy to share that our work with on how specific #glycans in human milk can be leveraged to reduce chronic inflammation and #atherosclerosis development is published in JCI Insight -https://insight.jci.org/articles/view/181329